Letter From Sister Mary Scullion: Expand Access to Medication Assisted Treatment (MAT) and Oppose SB 675
Sister Mary Scullion sent a letter to the Pennsylvania House Human Services Committee opposing SB 675 in anticipation of a committee vote on September 18, 2019.
SB 675 places unnecessary oversight, documentation requirements, and cost on providers operating outside of certified addiction treatment centers who prescribe buprenorphine for patients with opioid use disorder. This will harm Pennsylvania’s urgent efforts to make MAT widely available to all who need it as a key strategy to combat the opioid epidemic. Current requirements and oversight through the Drug Enforcement Agency are sufficient to ensure patient safety and regulate buprenorphine prescriptions. Many prescribers operate within comprehensive primary care sites, like community health centers, where counseling and other services are available.
Project HOME encourages the Pennsylvania House Human Services Committee to oppose SB 675.